{"indexed":{"date-parts":[[2019,11,25]],"date-time":"2019-11-25T15:34:49Z","timestamp":1574696089374},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"URL":"http:\/\/www.springer.com\/tdm","start":{"date-parts":[[2014,3,6]],"date-time":"2014-03-06T00:00:00Z","timestamp":1394064000000},"delay-in-days":0,"content-version":"tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1007\/s00198-014-2673-x","type":"article-journal","created":{"date-parts":[[2014,3,5]],"date-time":"2014-03-05T16:19:08Z","timestamp":1394036348000},"page":"1633-1642","source":"Crossref","is-referenced-by-count":40,"title":"Circulating irisin is associated with osteoporotic fractures in postmenopausal women with low bone mass but is not affected by either teriparatide or denosumab treatment for 3\u00a0months","prefix":"10.1007","volume":"25","author":[{"given":"A. D.","family":"Anastasilakis","sequence":"first","affiliation":[]},{"given":"S. A.","family":"Polyzos","sequence":"additional","affiliation":[]},{"given":"P.","family":"Makras","sequence":"additional","affiliation":[]},{"given":"A.","family":"Gkiomisi","sequence":"additional","affiliation":[]},{"given":"I.","family":"Bisbinas","sequence":"additional","affiliation":[]},{"given":"A.","family":"Katsarou","sequence":"additional","affiliation":[]},{"given":"A.","family":"Filippaios","sequence":"additional","affiliation":[]},{"given":"C. S.","family":"Mantzoros","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2014,3,6]]},"reference":[{"key":"2673_CR1","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1016\/S0140-6736(06)68891-0","volume":"367","author":"P Sambrook","year":"2006","unstructured":"Sambrook P, Cooper C (2006) Osteoporosis. Lancet 367:2010\u20132018","journal-title":"Lancet"},{"key":"2673_CR2","doi-asserted-by":"crossref","first-page":"295","DOI":"10.2147\/TCRM.S24239","volume":"8","author":"AD Anastasilakis","year":"2012","unstructured":"Anastasilakis AD, Toulis KA, Polyzos SA, Anastasilakis CD, Makras P (2012) Long-term treatment of osteoporosis: safety and efficacy appraisal of denosumab. Ther Clin Risk Manag 8:295\u2013306","journal-title":"Ther Clin Risk Manag"},{"key":"2673_CR3","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1210\/er.2004-0006","volume":"26","author":"A Hodsman","year":"2005","unstructured":"Hodsman A, Bauer D, Dempster D et al (2005) Parathyroid hormone and teriparatide for the treatment of osteoporosis: a review of the evidence and suggested guidelines for its use. Endocr Rev 26:688\u2013703","journal-title":"Endocr Rev"},{"key":"2673_CR4","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/nrendo.2012.49","volume":"8","author":"BK Pedersen","year":"2012","unstructured":"Pedersen BK, Febbraio MA (2012) Muscles, exercise and obesity: skeletal muscle as a secretory organ. Nat Rev Endocrinol 8:457\u2013465","journal-title":"Nat Rev Endocrinol"},{"key":"2673_CR5","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/nature10777","volume":"481","author":"P Bostr\u00f6m","year":"2012","unstructured":"Bostr\u00f6m P, Wu J, Jedrychowski MP et al (2012) A PGC1-\u03b1-dependent myokine that drives brown-fat-like development of white fat and thermogenesis. Nature 481:463\u2013468","journal-title":"Nature"},{"key":"2673_CR6","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1016\/j.metabol.2012.09.002","volume":"61","author":"JY Huh","year":"2012","unstructured":"Huh JY, Panagiotou G, Mougios V, Brinkoetter M, Vamvini MT, Schneider BE, Mantzoros CS (2012) FNDC5 and irisin in humans: I. Predictors of circulating concentrations in serum and plasma and II. mRNA expression and circulating concentrations in response to weight loss and exercise. Metabolism 61:1725\u20131738","journal-title":"Metabolism"},{"key":"2673_CR7","doi-asserted-by":"crossref","first-page":"e61903","DOI":"10.1371\/journal.pone.0061903","volume":"8","author":"H Staiger","year":"2013","unstructured":"Staiger H, B\u00f6hm A, Scheler M et al (2013) Common genetic variation in the human FNDC5 locus, encoding the novel muscle-derived \u2018browning\u2019 factor irisin, determines insulin sensitivity. PLoS One 8:e61903","journal-title":"PLoS One"},{"key":"2673_CR8","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/j.metabol.2013.04.008","volume":"62","author":"SA Polyzos","year":"2013","unstructured":"Polyzos SA, Kountouras J, Shields K, Mantzoros CS (2013) Irisin: a renaissance in metabolism? Metabolism 62:1037\u20131044","journal-title":"Metabolism"},{"issue":"8","key":"2673_CR9","doi-asserted-by":"crossref","first-page":"2687","DOI":"10.1210\/en.2012-2162","volume":"154","author":"S Rahman","year":"2013","unstructured":"Rahman S, Lu Y, Czernik PJ, Rosen CJ, Enerback S, Lecka-Czernik B (2013) Inducible brown adipose tissue, or beige fat, is anabolic for the skeleton. Endocrinology 154(8):2687\u20132701","journal-title":"Endocrinology"},{"key":"2673_CR10","unstructured":"Zhang J, Wu Y, Yu L, Meng S, Zhang L, Huang M, Tu Q, Chen JJ (2012) Exercise strengthens bone through myokine irisin. J Bone Miner Res 27 (Suppl 1). Available at http:\/\/www.asbmr.org\/Itinerary\/PresentationDetail.aspx?id=a8a0e3b4-1ca5-4b3e-b35a-307b043e1458 . Accessed 14\u201315 October 2012"},{"key":"2673_CR11","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1016\/j.metabol.2013.09.016","volume":"62","author":"AD DiVasta","year":"2013","unstructured":"DiVasta AD, Gordon CM (2013) Exercise and bone: where do we stand? Metabolism 62:1714\u20131717","journal-title":"Metabolism"},{"key":"2673_CR12","doi-asserted-by":"crossref","first-page":"E769","DOI":"10.1210\/jc.2012-2749","volume":"98","author":"JM Moreno-Navarrete","year":"2013","unstructured":"Moreno-Navarrete JM, Ortega F, Serrano M, Guerra E, Pardo G, Tinahones F, Ricart W, Fern\u00e1ndez-Real JM (2013) Irisin is expressed and produced by human muscle and adipose tissue in association with obesity and insulin resistance. J Clin Endocrinol Metab 98:E769\u2013E778","journal-title":"J Clin Endocrinol Metab"},{"key":"2673_CR13","doi-asserted-by":"crossref","first-page":"e64025","DOI":"10.1371\/journal.pone.0064025","volume":"8","author":"MS Wen","year":"2013","unstructured":"Wen MS, Wang CY, Lin SL, Hung KC (2013) Decrease in irisin in patients with chronic kidney disease. PLoS One 8:e64025","journal-title":"PLoS One"},{"key":"2673_CR14","doi-asserted-by":"crossref","first-page":"5266","DOI":"10.1210\/jc.2010-2317","volume":"95","author":"KE Ensrud","year":"2010","unstructured":"Ensrud KE, Ewing SK, Fredman L, Hochberg MC, Cauley JA, Hillier TA, Cummings SR, Yaffe K, Cawthon PM, Group SoOFR (2010) Circulating 25-hydroxyvitamin D levels and frailty status in older women. J Clin Endocrinol Metab 95:5266\u20135273","journal-title":"J Clin Endocrinol Metab"},{"key":"2673_CR15","doi-asserted-by":"crossref","first-page":"2997","DOI":"10.1210\/jc.2011-1193","volume":"96","author":"MH Murad","year":"2011","unstructured":"Murad MH, Elamin KB, Abu Elnour NO et al (2011) Clinical review: The effect of vitamin D on falls: a systematic review and meta-analysis. J Clin Endocrinol Metab 96:2997\u20133006","journal-title":"J Clin Endocrinol Metab"},{"key":"2673_CR16","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1111\/cen.12188","volume":"79","author":"P Makras","year":"2013","unstructured":"Makras P, Polyzos SA, Papatheodorou A, Kokkoris P, Chatzifotiadis D, Anastasilakis AD (2013) Parathyroid hormone changes following denosumab treatment in postmenopausal osteoporosis. Clin Endocrinol (Oxf) 79:499\u2013503","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2673_CR17","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1507\/endocrj.K07E-123","volume":"55","author":"AD Anastasilakis","year":"2008","unstructured":"Anastasilakis AD, Polyzos SA, Goulis DG, Slavakis A, Efstathiadou Z, Kita M, Koukoulis G, Avramidis A (2008) Endogenous intact PTH is suppressed during teriparatide (rhPTH 1-34) administration in postmenopausal women with established osteoporosis. Endocr J 55:613\u2013616","journal-title":"Endocr J"},{"key":"2673_CR18","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.metabol.2013.11.009","volume":"63","author":"PA Bostr\u00f6m","year":"2014","unstructured":"Bostr\u00f6m PA, Fern\u00e1ndez-Rea JM, Mantzoros CS (2014) Irisin in humans: recent advances and questions for future research. Metabolism 63:178\u2013180","journal-title":"Metabolism"}],"container-title":"Osteoporosis International","original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-014-2673-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00198-014-2673-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-014-2673-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T15:15:10Z","timestamp":1558624510000},"score":1.0,"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3,6]]},"references-count":18,"journal-issue":{"published-print":{"date-parts":[[2014,5]]},"issue":"5"},"alternative-id":["2673"],"URL":"http:\/\/dx.doi.org\/10.1007\/s00198-014-2673-x","relation":{"cites":[]},"ISSN":["0937-941X","1433-2965"],"subject":["Endocrinology, Diabetes and Metabolism"],"container-title-short":"Osteoporos Int"}